Medtech and Diagnostics

Symphera is a start-up based in Munich that is revolutionizing laparoscopic surgery with an innovative system that eliminates the need for manual instrument changes during operations. Symphera was founded in 2023 and emerged from the Technical University of Munich (TUM) and UnternehmerTUM. The company's vision is to significantly simplify surgical workflows in order to achieve better postoperative outcomes for patients.

Digital health services, insurers, and care providers across Europe use Thryve’s wearable API to raise interaction and therapy results with simple access to users’ continuous health data. Serving organisations from startups to governments and public institutions, Thryve offers a radically compliant solution to connect and understand data from 500+ wearables and health data sources through one, unified API. It is used for Wellness and Fitness, Remote Patient Monitoring, Digital Therapeutics, and Clinical Studies.

CereGate is restoring and reimagining human senses through a groundbreaking new communication channel with the brain. CereGate is transforming the treatment of neurological disorders with its innovative, minimally invasive Computer‑Brain Interface technology. It has been clinically tested in over 85 patients to address movement, balance, and sensory impairments.

Epignostix drives molecular tumour classification based on DNA methylation profiling and machine learning.

ACORAI develops a save sensor system to enable cardiac insight by combining Seismic, Acoustic, Visual, and Electrical sensors the Acorai Heart Monitor brings new rich data to healthcare. Cardiac insights are captured in real-time by Acorai’s machine learning engine which has been trained on one of the largest clinical datasets of its kind. A handheld format with an intuitive interface will integrate easily into daily practice.

inContAlert is a MedTech start-up developing a wearable to measure the filling level of the urinary bladder. With their sensor technology, body data is captured and analyzed with AI algorithms. The results are visualized within an app and warn patients in time about critical filling levels.

Aignostics started in 2018 within the walls of Charité Berlin and the Berlin Institute of Health, based on years of research conducted by the pathology department of Charité, TU Berlin and Fraunhofer HHI. Following initial incubation, it spun-out of Charité and BIH in 2020, and is now focusing on pioneering computational pathology for pharmaceutical research, clinical trials and CDx development.